APO Research
Talk to an analyst

APO RESEARCH · REPORT

Daptomycin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Daptomycin Market Analysis and Forecast 2026-2032

20 December 2025197 pages

Choose your research edition.

Industry ResearchDaptomycin Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Daptomycin Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Daptomycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Daptomycin Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Daptomycin Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Daptomycin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Daptomycin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Daptomycin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Daptomycin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Daptomycin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Daptomycin include HENGRUI PHARMA, Hisun, Sagent Pharmaceuticals, Xellia, Fresenius Kabi, Huadong Medicine, Pfizer, Mylan and Merck & Co., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Daptomycin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Daptomycin, also provides the sales of main regions and countries. Of the upcoming market potential for Daptomycin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Daptomycin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Daptomycin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Daptomycin sales, projected growth trends, production technology, application and end-user industry.

Daptomycin Segment by Company

HENGRUI PHARMA

Hisun

Sagent Pharmaceuticals

Xellia

Fresenius Kabi

Huadong Medicine

Pfizer

Mylan

Merck & Co.

Teva

Daptomycin Segment by Type

350 mg Lyophilized Powder

500 mg Lyophilized Powder

Daptomycin Segment by Application

Adult

Pediatric Patients (1 to 17 years of age)

Daptomycin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Daptomycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Daptomycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Daptomycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Daptomycin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Daptomycin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Daptomycin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Daptomycin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 350 mg Lyophilized Powder Major Manufacturers Table 3. 500 mg Lyophilized Powder Major Manufacturers Table 4. Global Daptomycin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Adult Major Manufacturers Table 6. Pediatric Patients (1 to 17 years of age) Major Manufacturers Table 7. Daptomycin Industry Trends Table 8. Daptomycin Industry Drivers Table 9. Daptomycin Industry Opportunities and Challenges Table 10. Daptomycin Industry Restraints Table 11. Global Daptomycin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Daptomycin Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Daptomycin Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Daptomycin Revenue Market Share by Region (2021-2026) Table 15. Global Daptomycin Revenue Market Share by Region (2027-2032) Table 16. Global Daptomycin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 17. Global Daptomycin Sales by Region (2021-2026) & (W Units) Table 18. Global Daptomycin Sales by Region (2027-2032) & (W Units) Table 19. Global Daptomycin Sales Market Share by Region (2021-2026) Table 20. Global Daptomycin Sales Market Share by Region (2027-2032) Table 21. Global Daptomycin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Daptomycin Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Daptomycin Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Daptomycin Sales Market Share by Manufacturers (2021-2026) Table 25. Global Daptomycin Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Daptomycin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Daptomycin Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Daptomycin Manufacturers, Product Type & Application Table 29. Global Daptomycin Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Daptomycin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Daptomycin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Daptomycin Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Daptomycin Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Daptomycin Revenue Market Share by Type (2021-2026) Table 36. Global Daptomycin Revenue Market Share by Type (2027-2032) Table 37. Global Daptomycin Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 38. Global Daptomycin Sales by Type (2021-2026) & (W Units) Table 39. Global Daptomycin Sales by Type (2027-2032) & (W Units) Table 40. Global Daptomycin Sales Market Share by Type (2021-2026) Table 41. Global Daptomycin Sales Market Share by Type (2027-2032) Table 42. Global Daptomycin Price by Type (2021-2026) & (US$/Unit) Table 43. Global Daptomycin Price by Type (2027-2032) & (US$/Unit) Table 44. Global Daptomycin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Daptomycin Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Daptomycin Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Daptomycin Revenue Market Share by Application (2021-2026) Table 48. Global Daptomycin Revenue Market Share by Application (2027-2032) Table 49. Global Daptomycin Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 50. Global Daptomycin Sales by Application (2021-2026) & (W Units) Table 51. Global Daptomycin Sales by Application (2027-2032) & (W Units) Table 52. Global Daptomycin Sales Market Share by Application (2021-2026) Table 53. Global Daptomycin Sales Market Share by Application (2027-2032) Table 54. Global Daptomycin Price by Application (2021-2026) & (US$/Unit) Table 55. Global Daptomycin Price by Application (2027-2032) & (US$/Unit) Table 56. HENGRUI PHARMA Company Information Table 57. HENGRUI PHARMA Business Overview Table 58. HENGRUI PHARMA Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. HENGRUI PHARMA Daptomycin Product Portfolio Table 60. HENGRUI PHARMA Recent Development Table 61. Hisun Company Information Table 62. Hisun Business Overview Table 63. Hisun Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Hisun Daptomycin Product Portfolio Table 65. Hisun Recent Development Table 66. Sagent Pharmaceuticals Company Information Table 67. Sagent Pharmaceuticals Business Overview Table 68. Sagent Pharmaceuticals Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Sagent Pharmaceuticals Daptomycin Product Portfolio Table 70. Sagent Pharmaceuticals Recent Development Table 71. Xellia Company Information Table 72. Xellia Business Overview Table 73. Xellia Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Xellia Daptomycin Product Portfolio Table 75. Xellia Recent Development Table 76. Fresenius Kabi Company Information Table 77. Fresenius Kabi Business Overview Table 78. Fresenius Kabi Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Fresenius Kabi Daptomycin Product Portfolio Table 80. Fresenius Kabi Recent Development Table 81. Huadong Medicine Company Information Table 82. Huadong Medicine Business Overview Table 83. Huadong Medicine Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Huadong Medicine Daptomycin Product Portfolio Table 85. Huadong Medicine Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Pfizer Daptomycin Product Portfolio Table 90. Pfizer Recent Development Table 91. Mylan Company Information Table 92. Mylan Business Overview Table 93. Mylan Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Mylan Daptomycin Product Portfolio Table 95. Mylan Recent Development Table 96. Merck & Co. Company Information Table 97. Merck & Co. Business Overview Table 98. Merck & Co. Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Merck & Co. Daptomycin Product Portfolio Table 100. Merck & Co. Recent Development Table 101. Teva Company Information Table 102. Teva Business Overview Table 103. Teva Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Teva Daptomycin Product Portfolio Table 105. Teva Recent Development Table 106. North America Daptomycin Revenue by Type (2021-2026) & (US$ Million) Table 107. North America Daptomycin Revenue by Type (2027-2032) & (US$ Million) Table 108. North America Daptomycin Sales by Type (2021-2026) & (W Units) Table 109. North America Daptomycin Sales by Type (2027-2032) & (W Units) Table 110. North America Daptomycin Sales Price by Type (2021-2026) & (US$/Unit) Table 111. North America Daptomycin Sales Price by Type (2027-2032) & (US$/Unit) Table 112. North America Daptomycin Revenue by Application (2021-2026) & (US$ Million) Table 113. North America Daptomycin Revenue by Application (2027-2032) & (US$ Million) Table 114. North America Daptomycin Sales by Application (2021-2026) & (W Units) Table 115. North America Daptomycin Sales by Application (2027-2032) & (W Units) Table 116. North America Daptomycin Sales Price by Application (2021-2026) & (US$/Unit) Table 117. North America Daptomycin Sales Price by Application (2027-2032) & (US$/Unit) Table 118. North America Daptomycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Daptomycin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 120. North America Daptomycin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 121. North America Daptomycin Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 122. North America Daptomycin Sales by Country (2021-2026) & (W Units) Table 123. North America Daptomycin Sales by Country (2027-2032) & (W Units) Table 124. North America Daptomycin Sales Price by Country (2021-2026) & (US$/Unit) Table 125. North America Daptomycin Sales Price by Country (2027-2032) & (US$/Unit) Table 126. United States Daptomycin Revenue (2021-2032) & (US$ Million) Table 127. Canada Daptomycin Revenue (2021-2032) & (US$ Million) Table 128. Europe Daptomycin Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe Daptomycin Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe Daptomycin Sales by Type (2021-2026) & (W Units) Table 131. Europe Daptomycin Sales by Type (2027-2032) & (W Units) Table 132. Europe Daptomycin Sales Price by Type (2021-2026) & (US$/Unit) Table 133. Europe Daptomycin Sales Price by Type (2027-2032) & (US$/Unit) Table 134. Europe Daptomycin Revenue by Application (2021-2026) & (US$ Million) Table 135. Europe Daptomycin Revenue by Application (2027-2032) & (US$ Million) Table 136. Europe Daptomycin Sales by Application (2021-2026) & (W Units) Table 137. Europe Daptomycin Sales by Application (2027-2032) & (W Units) Table 138. Europe Daptomycin Sales Price by Application (2021-2026) & (US$/Unit) Table 139. Europe Daptomycin Sales Price by Application (2027-2032) & (US$/Unit) Table 140. Europe Daptomycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Europe Daptomycin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. Europe Daptomycin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. Europe Daptomycin Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 144. Europe Daptomycin Sales by Country (2021-2026) & (W Units) Table 145. Europe Daptomycin Sales by Country (2027-2032) & (W Units) Table 146. Europe Daptomycin Sales Price by Country (2021-2026) & (US$/Unit) Table 147. Europe Daptomycin Sales Price by Country (2027-2032) & (US$/Unit) Table 148. Germany Daptomycin Revenue (2021-2032) & (US$ Million) Table 149. France Daptomycin Revenue (2021-2032) & (US$ Million) Table 150. U.K. Daptomycin Revenue (2021-2032) & (US$ Million) Table 151. Italy Daptomycin Revenue (2021-2032) & (US$ Million) Table 152. Netherlands Daptomycin Revenue (2021-2032) & (US$ Million) Table 153. China Daptomycin Revenue by Type (2021-2026) & (US$ Million) Table 154. China Daptomycin Revenue by Type (2027-2032) & (US$ Million) Table 155. China Daptomycin Sales by Type (2021-2026) & (W Units) Table 156. China Daptomycin Sales by Type (2027-2032) & (W Units) Table 157. China Daptomycin Sales Price by Type (2021-2026) & (US$/Unit) Table 158. China Daptomycin Sales Price by Type (2027-2032) & (US$/Unit) Table 159. China Daptomycin Revenue by Application (2021-2026) & (US$ Million) Table 160. China Daptomycin Revenue by Application (2027-2032) & (US$ Million) Table 161. China Daptomycin Sales by Application (2021-2026) & (W Units) Table 162. China Daptomycin Sales by Application (2027-2032) & (W Units) Table 163. China Daptomycin Sales Price by Application (2021-2026) & (US$/Unit) Table 164. China Daptomycin Sales Price by Application (2027-2032) & (US$/Unit) Table 165. Asia Daptomycin Revenue by Type (2021-2026) & (US$ Million) Table 166. Asia Daptomycin Revenue by Type (2027-2032) & (US$ Million) Table 167. Asia Daptomycin Sales by Type (2021-2026) & (W Units) Table 168. Asia Daptomycin Sales by Type (2027-2032) & (W Units) Table 169. Asia Daptomycin Sales Price by Type (2021-2026) & (US$/Unit) Table 170. Asia Daptomycin Sales Price by Type (2027-2032) & (US$/Unit) Table 171. Asia Daptomycin Revenue by Application (2021-2026) & (US$ Million) Table 172. Asia Daptomycin Revenue by Application (2027-2032) & (US$ Million) Table 173. Asia Daptomycin Sales by Application (2021-2026) & (W Units) Table 174. Asia Daptomycin Sales by Application (2027-2032) & (W Units) Table 175. Asia Daptomycin Sales Price by Application (2021-2026) & (US$/Unit) Table 176. Asia Daptomycin Sales Price by Application (2027-2032) & (US$/Unit) Table 177. Asia Daptomycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. Asia Daptomycin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. Asia Daptomycin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. Asia Daptomycin Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 181. Asia Daptomycin Sales by Country (2021-2026) & (W Units) Table 182. Asia Daptomycin Sales by Country (2027-2032) & (W Units) Table 183. Asia Daptomycin Sales Price by Country (2021-2026) & (US$/Unit) Table 184. Asia Daptomycin Sales Price by Country (2027-2032) & (US$/Unit) Table 185. Japan Daptomycin Revenue (2021-2032) & (US$ Million) Table 186. South Korea Daptomycin Revenue (2021-2032) & (US$ Million) Table 187. India Daptomycin Revenue (2021-2032) & (US$ Million) Table 188. Australia Daptomycin Revenue (2021-2032) & (US$ Million) Table 189. China Taiwan Daptomycin Revenue (2021-2032) & (US$ Million) Table 190. Southeast Asia Daptomycin Revenue (2021-2032) & (US$ Million) Table 191. SAMEA Daptomycin Revenue by Type (2021-2026) & (US$ Million) Table 192. SAMEA Daptomycin Revenue by Type (2027-2032) & (US$ Million) Table 193. SAMEA Daptomycin Sales by Type (2021-2026) & (W Units) Table 194. SAMEA Daptomycin Sales by Type (2027-2032) & (W Units) Table 195. SAMEA Daptomycin Sales Price by Type (2021-2026) & (US$/Unit) Table 196. SAMEA Daptomycin Sales Price by Type (2027-2032) & (US$/Unit) Table 197. SAMEA Daptomycin Revenue by Application (2021-2026) & (US$ Million) Table 198. SAMEA Daptomycin Revenue by Application (2027-2032) & (US$ Million) Table 199. SAMEA Daptomycin Sales by Application (2021-2026) & (W Units) Table 200. SAMEA Daptomycin Sales by Application (2027-2032) & (W Units) Table 201. SAMEA Daptomycin Sales Price by Application (2021-2026) & (US$/Unit) Table 202. SAMEA Daptomycin Sales Price by Application (2027-2032) & (US$/Unit) Table 203. SAMEA Daptomycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 204. SAMEA Daptomycin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 205. SAMEA Daptomycin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 206. SAMEA Daptomycin Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 207. SAMEA Daptomycin Sales by Country (2021-2026) & (W Units) Table 208. SAMEA Daptomycin Sales by Country (2027-2032) & (W Units) Table 209. SAMEA Daptomycin Sales Price by Country (2021-2026) & (US$/Unit) Table 210. SAMEA Daptomycin Sales Price by Country (2027-2032) & (US$/Unit) Table 211. Brazil Daptomycin Revenue (2021-2032) & (US$ Million) Table 212. Argentina Daptomycin Revenue (2021-2032) & (US$ Million) Table 213. Chile Daptomycin Revenue (2021-2032) & (US$ Million) Table 214. Colombia Daptomycin Revenue (2021-2032) & (US$ Million) Table 215. Peru Daptomycin Revenue (2021-2032) & (US$ Million) Table 216. Saudi Arabia Daptomycin Revenue (2021-2032) & (US$ Million) Table 217. Israel Daptomycin Revenue (2021-2032) & (US$ Million) Table 218. UAE Daptomycin Revenue (2021-2032) & (US$ Million) Table 219. Turkey Daptomycin Revenue (2021-2032) & (US$ Million) Table 220. Iran Daptomycin Revenue (2021-2032) & (US$ Million) Table 221. Egypt Daptomycin Revenue (2021-2032) & (US$ Million) Table 222. Key Raw Materials Table 223. Raw Materials Key Suppliers Table 224. Daptomycin Distributors List Table 225. Daptomycin Customers List Table 226. Research Programs/Design for This Report Table 227. Authors List of This Report Table 228. Secondary Sources Table 229. Primary Sources List of Figures Figure 1. Daptomycin Image Figure 2. Global Daptomycin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Daptomycin Market Size Share 2021 VS 2025 VS 2032 Figure 4. 350 mg Lyophilized Powder Image Figure 5. 500 mg Lyophilized Powder Image Figure 6. Global Daptomycin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Daptomycin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Adult Image Figure 9. Pediatric Patients (1 to 17 years of age) Image Figure 10. Global Daptomycin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Daptomycin Revenue (2021-2032) & (US$ Million) Figure 12. Global Daptomycin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Daptomycin Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Daptomycin Revenue Market Share by Region (2021-2032) Figure 15. Global Daptomycin Sales (2021-2032) & (W Units) Figure 16. Global Daptomycin Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 17. Global Daptomycin Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Daptomycin Sales YoY (2021-2032) & (W Units) Figure 19. Europe Daptomycin Sales YoY (2021-2032) & (W Units) Figure 20. China Daptomycin Sales YoY (2021-2032) & (W Units) Figure 21. Asia (Excluding China) Daptomycin Sales YoY (2021-2032) & (W Units) Figure 22. South America, Middle East and Africa Daptomycin Sales YoY (2021-2032) & (W Units) Figure 23. Global Daptomycin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Daptomycin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Daptomycin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Daptomycin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Daptomycin Revenue Market Share by Type (2021-2032) Figure 29. Global Daptomycin Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 30. Global Daptomycin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Daptomycin Sales Market Share by Type (2021-2032) Figure 32. Global Daptomycin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Daptomycin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Daptomycin Revenue Market Share by Application (2021-2032) Figure 35. Global Daptomycin Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 36. Global Daptomycin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Daptomycin Sales Market Share by Application (2021-2032) Figure 38. North America Daptomycin Revenue Share by Type (2021-2032) Figure 39. North America Daptomycin Sales Share by Type (2021-2032) Figure 40. North America Daptomycin Revenue Share by Application (2021-2032) Figure 41. North America Daptomycin Sales Share by Application (2021-2032) Figure 42. North America Daptomycin Revenue Share by Country (2021-2032) Figure 43. North America Daptomycin Sales Share by Country (2021-2032) Figure 44. Europe Daptomycin Revenue Share by Type (2021-2032) Figure 45. Europe Daptomycin Sales Share by Type (2021-2032) Figure 46. Europe Daptomycin Revenue Share by Application (2021-2032) Figure 47. Europe Daptomycin Sales Share by Application (2021-2032) Figure 48. Europe Daptomycin Revenue Share by Country (2021-2032) Figure 49. Europe Daptomycin Sales Share by Country (2021-2032) Figure 50. China Daptomycin Revenue Share by Type (2021-2032) Figure 51. China Daptomycin Sales Share by Type (2021-2032) Figure 52. China Daptomycin Revenue Share by Application (2021-2032) Figure 53. China Daptomycin Sales Share by Application (2021-2032) Figure 54. Asia Daptomycin Revenue Share by Type (2021-2032) Figure 55. Asia Daptomycin Sales Share by Type (2021-2032) Figure 56. Asia Daptomycin Revenue Share by Application (2021-2032) Figure 57. Asia Daptomycin Sales Share by Application (2021-2032) Figure 58. Asia Daptomycin Revenue Share by Country (2021-2032) Figure 59. Asia Daptomycin Sales Share by Country (2021-2032) Figure 60. SAMEA Daptomycin Revenue Share by Type (2021-2032) Figure 61. SAMEA Daptomycin Sales Share by Type (2021-2032) Figure 62. SAMEA Daptomycin Revenue Share by Application (2021-2032) Figure 63. SAMEA Daptomycin Sales Share by Application (2021-2032) Figure 64. SAMEA Daptomycin Revenue Share by Country (2021-2032) Figure 65. SAMEA Daptomycin Sales Share by Country (2021-2032) Figure 66. Daptomycin Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Daptomycin Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 350 mg Lyophilized Powder
  • 500 mg Lyophilized Powder
Applications
  • Adult
  • Pediatric Patients (1 to 17 years of age)
Companies covered
  • HENGRUI PHARMA
  • Hisun
  • Sagent Pharmaceuticals
  • Xellia
  • Fresenius Kabi
  • Huadong Medicine
  • Pfizer
  • Mylan
  • Merck & Co.
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Daptomycin Market by Type
  3. 1.2.1 Global Daptomycin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 350 mg Lyophilized Powder
  5. 1.2.3 500 mg Lyophilized Powder
  6. 1.3 Daptomycin Market by Application
  7. 1.3.1 Global Daptomycin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Adult
  9. 1.3.3 Pediatric Patients (1 to 17 years of age)
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Daptomycin Market Dynamics
  1. 2.1 Daptomycin Industry Trends
  2. 2.2 Daptomycin Industry Drivers
  3. 2.3 Daptomycin Industry Opportunities and Challenges
  4. 2.4 Daptomycin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Daptomycin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Daptomycin Revenue by Region
  3. 3.2.1 Global Daptomycin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Daptomycin Revenue by Region (2021-2026)
  5. 3.2.3 Global Daptomycin Revenue by Region (2027-2032)
  6. 3.2.4 Global Daptomycin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Daptomycin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Daptomycin Sales by Region
  9. 3.4.1 Global Daptomycin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Daptomycin Sales by Region (2021-2026)
  11. 3.4.3 Global Daptomycin Sales by Region (2027-2032)
  12. 3.4.4 Global Daptomycin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Daptomycin Revenue by Manufacturers
  2. 4.1.1 Global Daptomycin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Daptomycin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Daptomycin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Daptomycin Sales by Manufacturers
  6. 4.2.1 Global Daptomycin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Daptomycin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Daptomycin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Daptomycin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Daptomycin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Daptomycin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Daptomycin Manufacturers, Product Type & Application
  13. 4.7 Global Daptomycin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Daptomycin Market CR5 and HHI
  16. 4.8.2 2025 Daptomycin Tier 1, Tier 2, and Tier 3
5 Daptomycin Market by Type
  1. 5.1 Global Daptomycin Revenue by Type
  2. 5.1.1 Global Daptomycin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Daptomycin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Daptomycin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Daptomycin Sales by Type
  6. 5.2.1 Global Daptomycin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Daptomycin Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Daptomycin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Daptomycin Price by Type
6 Daptomycin Market by Application
  1. 6.1 Global Daptomycin Revenue by Application
  2. 6.1.1 Global Daptomycin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Daptomycin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Daptomycin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Daptomycin Sales by Application
  6. 6.2.1 Global Daptomycin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Daptomycin Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Daptomycin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Daptomycin Price by Application
7 Company Profiles
  1. 7.1 HENGRUI PHARMA
  2. 7.1.1 HENGRUI PHARMA Company Information
  3. 7.1.2 HENGRUI PHARMA Business Overview
  4. 7.1.3 HENGRUI PHARMA Daptomycin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 HENGRUI PHARMA Daptomycin Product Portfolio
  6. 7.1.5 HENGRUI PHARMA Recent Developments
  7. 7.2 Hisun
  8. 7.2.1 Hisun Company Information
  9. 7.2.2 Hisun Business Overview
  10. 7.2.3 Hisun Daptomycin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Hisun Daptomycin Product Portfolio
  12. 7.2.5 Hisun Recent Developments
  13. 7.3 Sagent Pharmaceuticals
  14. 7.3.1 Sagent Pharmaceuticals Company Information
  15. 7.3.2 Sagent Pharmaceuticals Business Overview
  16. 7.3.3 Sagent Pharmaceuticals Daptomycin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sagent Pharmaceuticals Daptomycin Product Portfolio
  18. 7.3.5 Sagent Pharmaceuticals Recent Developments
  19. 7.4 Xellia
  20. 7.4.1 Xellia Company Information
  21. 7.4.2 Xellia Business Overview
  22. 7.4.3 Xellia Daptomycin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Xellia Daptomycin Product Portfolio
  24. 7.4.5 Xellia Recent Developments
  25. 7.5 Fresenius Kabi
  26. 7.5.1 Fresenius Kabi Company Information
  27. 7.5.2 Fresenius Kabi Business Overview
  28. 7.5.3 Fresenius Kabi Daptomycin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Fresenius Kabi Daptomycin Product Portfolio
  30. 7.5.5 Fresenius Kabi Recent Developments
  31. 7.6 Huadong Medicine
  32. 7.6.1 Huadong Medicine Company Information
  33. 7.6.2 Huadong Medicine Business Overview
  34. 7.6.3 Huadong Medicine Daptomycin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Huadong Medicine Daptomycin Product Portfolio
  36. 7.6.5 Huadong Medicine Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Daptomycin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Daptomycin Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 Mylan
  44. 7.8.1 Mylan Company Information
  45. 7.8.2 Mylan Business Overview
  46. 7.8.3 Mylan Daptomycin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Mylan Daptomycin Product Portfolio
  48. 7.8.5 Mylan Recent Developments
  49. 7.9 Merck & Co.
  50. 7.9.1 Merck & Co. Company Information
  51. 7.9.2 Merck & Co. Business Overview
  52. 7.9.3 Merck & Co. Daptomycin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Merck & Co. Daptomycin Product Portfolio
  54. 7.9.5 Merck & Co. Recent Developments
  55. 7.10 Teva
  56. 7.10.1 Teva Company Information
  57. 7.10.2 Teva Business Overview
  58. 7.10.3 Teva Daptomycin Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Teva Daptomycin Product Portfolio
  60. 7.10.5 Teva Recent Developments
8 North America
  1. 8.1 North America Daptomycin Market Size by Type
  2. 8.1.1 North America Daptomycin Revenue by Type (2021-2032)
  3. 8.1.2 North America Daptomycin Sales by Type (2021-2032)
  4. 8.1.3 North America Daptomycin Price by Type (2021-2032)
  5. 8.2 North America Daptomycin Market Size by Application
  6. 8.2.1 North America Daptomycin Revenue by Application (2021-2032)
  7. 8.2.2 North America Daptomycin Sales by Application (2021-2032)
  8. 8.2.3 North America Daptomycin Price by Application (2021-2032)
  9. 8.3 North America Daptomycin Market Size by Country
  10. 8.3.1 North America Daptomycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Daptomycin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Daptomycin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Daptomycin Market Size by Type
  2. 9.1.1 Europe Daptomycin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Daptomycin Sales by Type (2021-2032)
  4. 9.1.3 Europe Daptomycin Price by Type (2021-2032)
  5. 9.2 Europe Daptomycin Market Size by Application
  6. 9.2.1 Europe Daptomycin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Daptomycin Sales by Application (2021-2032)
  8. 9.2.3 Europe Daptomycin Price by Application (2021-2032)
  9. 9.3 Europe Daptomycin Market Size by Country
  10. 9.3.1 Europe Daptomycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Daptomycin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Daptomycin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Daptomycin Market Size by Type
  2. 10.1.1 China Daptomycin Revenue by Type (2021-2032)
  3. 10.1.2 China Daptomycin Sales by Type (2021-2032)
  4. 10.1.3 China Daptomycin Price by Type (2021-2032)
  5. 10.2 China Daptomycin Market Size by Application
  6. 10.2.1 China Daptomycin Revenue by Application (2021-2032)
  7. 10.2.2 China Daptomycin Sales by Application (2021-2032)
  8. 10.2.3 China Daptomycin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Daptomycin Market Size by Type
  2. 11.1.1 Asia Daptomycin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Daptomycin Sales by Type (2021-2032)
  4. 11.1.3 Asia Daptomycin Price by Type (2021-2032)
  5. 11.2 Asia Daptomycin Market Size by Application
  6. 11.2.1 Asia Daptomycin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Daptomycin Sales by Application (2021-2032)
  8. 11.2.3 Asia Daptomycin Price by Application (2021-2032)
  9. 11.3 Asia Daptomycin Market Size by Country
  10. 11.3.1 Asia Daptomycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Daptomycin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Daptomycin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Daptomycin Market Size by Type
  2. 12.1.1 SAMEA Daptomycin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Daptomycin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Daptomycin Price by Type (2021-2032)
  5. 12.2 SAMEA Daptomycin Market Size by Application
  6. 12.2.1 SAMEA Daptomycin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Daptomycin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Daptomycin Price by Application (2021-2032)
  9. 12.3 SAMEA Daptomycin Market Size by Country
  10. 12.3.1 SAMEA Daptomycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Daptomycin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Daptomycin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Daptomycin Value Chain Analysis
  2. 13.1.1 Daptomycin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Daptomycin Production Mode & Process
  6. 13.2 Daptomycin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Daptomycin Distributors
  9. 13.2.3 Daptomycin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst